Sildenafil is often a powerful and selective inhibitor of cGMP-certain phosphodiesterase type five (PDE5), and that is chargeable for degradation of cGMP during the corpus cavernosum. The molecular framework of sildenafil is comparable to that of cGMP and acts like a aggressive binding agent of PDE5